Mark Massaro
Stock Analyst at BTIG
(4.51)
# 270
Out of 5,124 analysts
179
Total ratings
55.06%
Success rate
20.4%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Maintains: Buy | $21 → $22 | $15.77 | +39.51% | 8 | Feb 6, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $830 → $800 | $644.61 | +24.11% | 3 | Feb 3, 2026 | |
| PSNL Personalis | Reiterates: Buy | $12 | $8.06 | +48.98% | 4 | Jan 9, 2026 | |
| MDXH MDxHealth | Reiterates: Buy | $7 | $3.54 | +97.74% | 10 | Dec 23, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $140 | $101.85 | +37.46% | 7 | Dec 12, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $165 → $200 | $84.29 | +137.28% | 7 | Dec 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $38 → $50 | $32.76 | +52.63% | 6 | Dec 12, 2025 | |
| BLLN BillionToOne | Reiterates: Buy | $160 | $90.61 | +76.58% | 2 | Dec 10, 2025 | |
| NTRA Natera | Maintains: Buy | $230 → $260 | $203.04 | +28.05% | 16 | Dec 5, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $160 | $127.42 | +25.57% | 4 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $105 | $54.91 | +91.22% | 6 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $103.18 | - | 20 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $3.51 | +327.35% | 5 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $4.80 | +45.83% | 3 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $19.47 | +28.40% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.22 | +104.92% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $10.10 | -10.89% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.81 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.15 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $11.42 | +83.89% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.25 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.20 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $119.72 | +150.58% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $74.81 | -33.16% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $190.71 | -41.27% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $277.20 | -40.48% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $29.10 | +174.91% | 9 | Sep 10, 2018 |
Adaptive Biotechnologies
Feb 6, 2026
Maintains: Buy
Price Target: $21 → $22
Current: $15.77
Upside: +39.51%
IDEXX Laboratories
Feb 3, 2026
Maintains: Buy
Price Target: $830 → $800
Current: $644.61
Upside: +24.11%
Personalis
Jan 9, 2026
Reiterates: Buy
Price Target: $12
Current: $8.06
Upside: +48.98%
MDxHealth
Dec 23, 2025
Reiterates: Buy
Price Target: $7
Current: $3.54
Upside: +97.74%
Guardant Health
Dec 12, 2025
Maintains: Buy
Price Target: $100 → $140
Current: $101.85
Upside: +37.46%
GeneDx Holdings
Dec 12, 2025
Maintains: Buy
Price Target: $165 → $200
Current: $84.29
Upside: +137.28%
Castle Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $38 → $50
Current: $32.76
Upside: +52.63%
BillionToOne
Dec 10, 2025
Reiterates: Buy
Price Target: $160
Current: $90.61
Upside: +76.58%
Natera
Dec 5, 2025
Maintains: Buy
Price Target: $230 → $260
Current: $203.04
Upside: +28.05%
Zoetis
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $127.42
Upside: +25.57%
Nov 25, 2025
Maintains: Buy
Price Target: $96 → $105
Current: $54.91
Upside: +91.22%
Nov 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $103.18
Upside: -
Nov 10, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $3.51
Upside: +327.35%
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $4.80
Upside: +45.83%
Nov 6, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $19.47
Upside: +28.40%
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.22
Upside: +104.92%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $10.10
Upside: -10.89%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.81
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $11.42
Upside: +83.89%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.25
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.20
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $119.72
Upside: +150.58%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $74.81
Upside: -33.16%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $190.71
Upside: -41.27%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $277.20
Upside: -40.48%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $29.10
Upside: +174.91%